RASD1 and neoplasm: To explore the potential tumor suppressive mechanisms of RASD1 in KIRC, LGG, and PAAD, we used GEPIA2 to identify the top 50 genes (Table 1) with similar expression patterns as RASD1 in these three cancers for which high RASD1 expression correlated with better survival outcomes.